Navigation Links
Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Date:2/6/2008

NA. There was no evidence of the selection of PSI-6130 resistant virus in any dose cohort during the 2 weeks of dosing.

The preliminary results of a 4 week Phase 1 clinical trial to evaluate two oral dose levels of R7128 in combination with Pegasys(R) (pegylated interferon) plus Copegus(R) (ribavirin) in 50 treatment-naive patients chronically infected with HCV genotype 1 demonstrated potent short-term antiviral activity. Eighty-five (85%) of patients receiving R7128 1500mg and Pegasys plus Copegus (n=20) achieved undetectable HCV RNA levels following 4 weeks of treatment, or rapid virologic response. The R7128 combination cohorts demonstrated safety and tolerability comparable to placebo with Pegasys plus Copegus.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a 4-week Phase 1 clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in thi
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche responds to announcement of IDEAL hepatitis C trial results
2. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
3. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
4. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
5. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
6. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
10. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
11. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 ... having achieved dazzling export-led growth in just 4 ... celebrates its part in winning the Queen,s Award ... awarded to Oxford PharmaGenesis. As part of the ... its clients bring new medicines to the world ...
(Date:4/21/2015)... England , April 21, 2015 ... Queen,s Award for Enterprise, having more than doubled its ... Oxford PharmaGenesis today celebrates winning the Queen,s Award ... local employer is the world,s first HealthScience Communications consultancy, ... in areas of patient need. Having more than doubled ...
(Date:4/21/2015)... 21, 2015 Softheon, Inc., ... and business operation, has confirmed its status as ... of Medicare & Medicaid Services (CMS).  Under this ... access to the Federal Data Hub to assist ... qualified health insurance plans. Through ...
Breaking Medicine Technology:Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Softheon Confirms Web Broker Entity (WBE) Status with the Centers of Medicare & Medicaid Services (CMS) 2
... Primate trials validate efficacy of the processTHOUSAND OAKS, Calif., ... it has successfully completed the initial primate trials validating ... (NELL-1) protein in spinal fusion surgery. 100% fusion ... cystic lesion was observed. The company is currently ...
... experienced mild head trauma or a blast exposure while serving ... with headaches, according to a study released today that will ... Meeting in Seattle, April 25 to May 2, 2009.The study, ... returning from Iraq or Afghanistan in 2008. All had experienced ...
Cached Medicine Technology:Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2For Iraq Veterans, Headaches Continue After Traumatic Brain Injury 2
(Date:4/21/2015)... Approximately 75 million Americans live in areas with ... (EPA). On top of this, consuming alcohol and exposure ... of toxins found in the body. A natural way ... to increase consumption of broccoli. Considered by many as ... – a long-lasting antioxidant – of all cruciferous vegetables. ...
(Date:4/21/2015)... Insuranceautoquote.info has released a new blog post ... . , Collision auto insurance is a policy ... Unlike liability coverage, collision auto insurance also covers the ... benefits to cover the insured’s expenses. , ... provide all the necessary resources for comparing online car ...
(Date:4/21/2015)... As a provider of holistic, result-driven ... their rehabilitation strategy, which involves various treatment modalities, produces ... an effort to offer hope and encouragement to those ... Best Drug Rehabilitation has featured a series of stories ... graduates of their recovery program. , One of ...
(Date:4/21/2015)... 21, 2015 Dr. Aaron Choroomi, dentist ... Group are now offering a valuable discount on restorative dental ... the promotional price of only $1695 for a limited time. ... patients for a limited time. , "There are times ... on the price," dental implants dentist , Dr. Choroomi, ...
(Date:4/21/2015)... Salt Lake City, Utah (PRWEB) April 21, 2015 ... insurance reimbursement for small businesses, announced today the publication ... , Recent health reform brought changes to the ... These changes caused some business owners to question what ... to use eBook helps small business owners determine which ...
Breaking Medicine News(10 mins):Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Collision Auto Insurance Covers Many Damages And Car Repairs 2Health News:Best Drug Rehabilitation Graduate Discusses Making Amends and Rebuilding Relationships 2Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2
... key to developing effective anti-skin cancer drugs, thanks to ... East Anglia (UEA). , The scientists have identified a ... the movement of the pigment cells that give the ... familiar greenish-brown of the adult frog. , It is ...
... 2008 Top 20 Best in KLAS Awards Also Ranks ... CTG HealthCare Solutions (CTGHS), a leading healthcare information ... CTG (Nasdaq: CTGX ), an international IT ... ranked second in the overall professional services firm rankings ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) confirmed ... with the Securities and Exchange Commission from Amylin shareholder ... to nominate a slate of five directors to stand ... has not yet received the required notice with respect ...
... Diabetes and Digestive and Kidney Diseases has awarded a ... Graduate School of Public Health to coordinate the Hepatitis ... clinical and research centers in the U.S. and Canada ... , The network will include a multi-site treatment ...
... Two new studies found that exercise may be a ... knee arthroplasty or TKA) and knee osteoarthritis (OA). One ... knee replacement found that it enhanced clinical improvement almost ... study, the first to examine the relationship between four ...
... Jan. 29 Dr. Rachel Bennett, a noted infertility ... from Yorktown Heights to Mount Kisco, effective this month. ... range of infertility treatment options to women and men ... treating every patient with expert medical care and compassion. ...
Cached Medicine News:Health News:Skin color studies on tadpoles lead to cancer advance 2Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 2Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 3Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 4Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 2Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 3Health News:Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco 2
... Microdiscectomy System incorporates specially designed metal tubes ... area in a minimally invasive manner. These ... from 5.3 mm to 20.8 mm. The ... - one around the other - through ...
Fortitude as a unique complement to the spinal concepts family of products....
... Cougar is an Anterior Spinal Implant ... elasticity approximating that of cortical bone. The ... structural requirements of anterior column support, while ... load sharing design. Incorporates an anatomic design ...
Cervical Tissue Retractor 13 cm - 5 1/8, one blunt prong, 13 mm deep....
Medicine Products: